KRAS and lung cancer: As expected, BKA-073 significantly reduced tumor burden in the lungs of KL mice leading to prolonged survival when compared with the untreated control group, suggesting that BKA-073 has the potential to improve the prognosis of patients with mutant KRAS-driven lung cancer.